Table 7.
Multidrug resistance pattern of Gram-positive bacteria isolated from pediatric patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia, 2014.
| Combination of antibacterial agent | Enterococcus spp. no. (%) | S. aureus no. (%) | CONS no. (%) | Total no. (%) |
|---|---|---|---|---|
| P, AMP, KF | — | 1 (100) | — | 1 (9.09) |
| P, SXT, E, CXM | — | — | 3 (75) | 3 (27.2) |
| P, SXT, E, C | 2 (33.3) | — | — | 2 (18.2) |
| P, SXT, E, C, AMP | 1 (16.7) | — | 1 (25) | 2 (18.2) |
| CXM, E, F, AMP, SXT | 1 (16.7) | — | — | 1 (9.09) |
| CXM, E, F, KF, CRO, SXT, C | 1 (16.7) | — | — | 1 (9.09) |
| C, E, F, KF, CRO, SXT | 1 (16.7) | — | — | 1 (9.09) |
| Total | 6 (100) | 1 (100) | 4 (100) | 11 (100) |
CONS: coagulase-negative staphylococci; P: penicillin (10 U); AMP: augmentin (30 μg); KF: cephalothin (10 μg); DA: clindamycin (30 μg); CRO: ceftriaxone (10 μg); GN: gentamicin (30 μg); E: erythromycin (15 μg); CIP: ciprofloxacin (5 μg); OX: oxacillin (1 μg); F: nitrofurantoin (30 μg); C: chloramphenicol (30 μg); SXT: trimethoprim-sulfamethoxazole (1.25/23.75 μg); CXM: cefuroxime (30 μg).